Chongbiao Huang
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 12
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 12
- Cancer Cells and Metastasis 8
- Lung Cancer Research Studies 5
- Immunology top 5%
- Phagocytosis and Immune Regulation 6
- Immune cells in cancer 5
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 6
- RNA modifications and cancer 6
- Physiology top 10%
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Chongbiao Huang
49 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 93
- Cancer Research 598
- Oncology 765
- Immunology 439
- Molecular Biology 824
- Physiology 42
Countries citing papers authored by Chongbiao Huang
This map shows the geographic impact of Chongbiao Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chongbiao Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chongbiao Huang more than expected).
Fields of papers citing papers by Chongbiao Huang
This network shows the impact of papers produced by Chongbiao Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chongbiao Huang. The network helps show where Chongbiao Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chongbiao Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 15 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 18 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 6 | |
| 6 | 2022 | 22 | |
| 7 | 2022 | 76 | |
| 8 | 2022 | 11 | |
| 9 | 2021 | 33 | |
| 10 | 2021 | 25 | |
| 11 | 2020 | 14 | |
| 12 | 2020 | 43 | |
| 13 | 2019 | 43 | |
| 14 | 2019 | 55 | |
| 15 | 2019 | 22 | |
| 16 | 2019 | 24 | |
| 17 | 2017 | 35 | |
| 18 | 2016 | 45 | |
| 19 | 2015 | 14 | |
| 20 | 2014 | 84 |
About Chongbiao Huang
Chongbiao Huang is a scholar working on Cancer Research, Oncology and Immunology, having authored 49 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (12 papers), Cancer, Hypoxia, and Metabolism (12 papers), Cancer Cells and Metastasis (8 papers), Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (6 papers), Phagocytosis and Immune Regulation (6 papers), Lung Cancer Research Studies (5 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Cancer Research (598 citations), Oncology (765 citations) and Immunology (439 citations). Chongbiao Huang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiuchao Wang, Jihui Hao, Tiansuo Zhao, Shengyu Yang, Zengxun Li, Song Gao, He Ren, He Ren, Hongwei Wang and Jie Dong. Their work appears in journals such as Cancer Letters, Cancer Research, Gastroenterology, Nature Communications and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.